&Partners’s Hologic HOLX Stock Holding History

&Partners’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,740	Closed	-$207K	–	2536
2026 Q1	$207K	Sell	2,740 -1,102	-29%	-$82.9K	﹤0.01%	2230
2025 Q4	$286K	Sell	3,842 -2,016	-34%	-$147K	﹤0.01%	1947
2025 Q3	$389K	Buy	5,858 +582	+11%	+$38.6K	﹤0.01%	1607
2025 Q2	$349K	Buy	5,276 +685	+15%	+$41.1K	﹤0.01%	1544
2025 Q1	$282K	Buy	4,591 +1,154	+34%	+$76.5K	﹤0.01%	1439
2024 Q4	$252K	Sell	3,437 -297	-8%	-$23.2K	﹤0.01%	1422
2024 Q3	$303K	Buy	+3,734	New	+$299K	0.01%	1094

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

&Partners's HOLX Position: Q2 2026 in Review

&Partners sold out of Hologic (HOLX) in Q2 2026, closing a stake of 2,740 shares — an estimated $207K sold.

&Partners first reported a position in HOLX in Q3 2024 and held it in 7 quarters. The position peaked at $389K in Q3 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

&Partners reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
&Partners sold 2,740 Hologic shares in Q2 2026, an estimated $207K.
&Partners first reported a position in Hologic in Q3 2024 and held it in 7 quarters.
&Partners's Hologic position peaked at $389K in Q3 2025.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.